[go: up one dir, main page]

ATE424896T1 - Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst - Google Patents

Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst

Info

Publication number
ATE424896T1
ATE424896T1 AT06754908T AT06754908T ATE424896T1 AT E424896 T1 ATE424896 T1 AT E424896T1 AT 06754908 T AT06754908 T AT 06754908T AT 06754908 T AT06754908 T AT 06754908T AT E424896 T1 ATE424896 T1 AT E424896T1
Authority
AT
Austria
Prior art keywords
active ingredient
depigmentizing
oxazoline
cosmetic composition
depigmenting
Prior art date
Application number
AT06754908T
Other languages
English (en)
Inventor
Nathalie Piccardi
Philippe Msika
Original Assignee
Expanscience Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expanscience Lab filed Critical Expanscience Lab
Application granted granted Critical
Publication of ATE424896T1 publication Critical patent/ATE424896T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT06754908T 2005-04-27 2006-04-27 Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst ATE424896T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504227A FR2885128B1 (fr) 2005-04-27 2005-04-27 Composition cosmetique a visee depigmentante ou eclaircissante comprenant au moins une oxazoline, a titre de principe actif depigmentant ou eclaircissant

Publications (1)

Publication Number Publication Date
ATE424896T1 true ATE424896T1 (de) 2009-03-15

Family

ID=35478674

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06754908T ATE424896T1 (de) 2005-04-27 2006-04-27 Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst

Country Status (13)

Country Link
US (1) US8722023B2 (de)
EP (1) EP1874410B1 (de)
JP (1) JP5010582B2 (de)
KR (1) KR101309569B1 (de)
CN (1) CN101198377B (de)
AT (1) ATE424896T1 (de)
DE (1) DE602006005637D1 (de)
ES (1) ES2322198T3 (de)
FR (1) FR2885128B1 (de)
HK (1) HK1111924A1 (de)
MX (1) MX2007013449A (de)
PL (1) PL1874410T3 (de)
WO (1) WO2006114443A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100316584A1 (en) * 2008-02-08 2010-12-16 Shiseido Company Ltd. Whitening Agent And Skin External Preparation
DK2814489T3 (en) * 2012-02-17 2017-10-30 Epitech Group S P A COMPOSITIONS AND PROCEDURES FOR MODULATING SPECIFIC AMIDASES FOR N-ACYLETHANOLAMINES FOR USE IN THE THERAPY OF INFLAMMATORY DISEASES
FR3098394B1 (fr) 2019-07-12 2022-07-08 Expanscience Lab Composition comprenant au moins une oxazoline pour inhiber la croissance de levure du genre Malassezia impliquée notamment dans les croûtes de lait
FR3098405B1 (fr) 2019-07-12 2021-06-25 Expanscience Lab Composition comprenant des polyphénols de graines de passiflore, des peptides d’avocat et un extrait d’hamamélis et utilisation pour traiter et/ou prévenir les vergetures

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6281011A (ja) * 1985-10-04 1987-04-14 Komatsu Ltd 比例ソレノイドの制御装置
US5686489A (en) * 1986-12-23 1997-11-11 Tristrata Technology, Inc. Alpha hydroxyacid esters for skin aging
US4876249A (en) * 1987-01-12 1989-10-24 Rajadhyaksha Vithal J Compositions and method comprising heterocyclic compounds containing two heteroatoms
JP2506384B2 (ja) * 1987-09-25 1996-06-12 三省製薬株式会社 外用剤
US6750229B2 (en) * 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
FR2834216B1 (fr) * 2001-12-27 2004-04-30 Pharmascience Lab Composition cosmetique ou pharmaceutique comprenant au moins une oxazoline pour inhiber la migration des cellules de langerhans, et ses utilisations
FR2856294B1 (fr) * 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
FR2934216B1 (fr) 2008-07-22 2018-10-26 Renault Sas Procede de freinage a recuperation d'energie pour un vehicule automobile

Also Published As

Publication number Publication date
PL1874410T3 (pl) 2009-07-31
EP1874410B1 (de) 2009-03-11
FR2885128A1 (fr) 2006-11-03
KR20080000641A (ko) 2008-01-02
ES2322198T3 (es) 2009-06-17
JP2008539206A (ja) 2008-11-13
KR101309569B1 (ko) 2013-09-17
US8722023B2 (en) 2014-05-13
FR2885128B1 (fr) 2007-07-06
HK1111924A1 (en) 2008-08-22
MX2007013449A (es) 2008-01-21
EP1874410A1 (de) 2008-01-09
DE602006005637D1 (de) 2009-04-23
CN101198377A (zh) 2008-06-11
JP5010582B2 (ja) 2012-08-29
CN101198377B (zh) 2011-01-05
WO2006114443A1 (fr) 2006-11-02
US20090274637A1 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
HK1091151A1 (en) Cosmetic use of a composition containing at least one oxazoline, serving as an active substance, as a slimming product and/or for preventing and/or treating cellulite
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
TW200637522A (en) Skin treatment articles and methods
EP2144590A4 (de) Hautbehandlungszusammensetzungen und -verfahren
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
WO2007029187A3 (en) Use of protoberberines as an active substance regulating the pilosebaceous unit
CA2713555C (en) Topical compositions and methods for whitening skin
FR2927254B1 (fr) Utilisation de substances actives naturelles dans des compositions cosmetiques ou therapeutiques
WO2007031793A8 (en) Improvements in or relatimg to cosmetic compositions
MY143795A (en) Tetrahydropyridoindole derivatives
HK1150027A1 (en) Preparation for preventing or ameliorating wrinkles, to be taken orally, through injection, or through external application to skin, and cosmetic method
WO2007128939A3 (fr) Association d'un agent ou dispositif tenseur et d'un compose saccharidique
PL1962815T3 (pl) Zastosowanie błonotwórczych polimerów do pielęgnacji włosów z grupy poluretanów i zawierające te polimery preparaty i plastry farmaceutyczne
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
NO20091517L (no) Emulsjon
PL1893237T3 (pl) Kompozycja farmaceutyczna zawierająca elastomer poliorganosiloksanowy i solubilizowany składnik aktywny
ATE424896T1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
WO2007025994A3 (fr) Utilisation d'au moins un 2-alkyle furane, a titre de principe actif depigmentant ou eclaircissant
WO2008125789A3 (fr) Utilisation d'un extrait d'algue phaeodactylum pour depigmenter la peau
WO2005034857A8 (en) Methods and compositions comprising diamines as new anti-tubercular therapeutics
EP1660620A4 (de) Verfahren zur verminderung von irritationen bei körperpflegemitteln
BRPI0819010A2 (pt) "composição de cuidado pessoal, método para depositar um agente de ativação e método para aliviar a coceira no couro cabeludo"
PL2066409T3 (pl) Zastosowanie ekstraktu z quinoa jako kosmetycznego i farmaceutycznego środka czynnego odchudzającego i/lub jako środka czynnego zapobiegającego tworzeniu się nowych tłuszczów w ludzkim ciele
FR2912055B1 (fr) Composition cosmetique comprenant des actifs anti-inflammatoires, reparateurs, apaisants et hydratants pour calmer l'irritation de la peau
WO2013092888A3 (en) Lightening process using a composition rich in fatty substances and metal catalysts, and device suitable therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties